...
机译:急性白血病免疫组织化学:一种系统的诊断方法
Randall J. Olsen, MD, PhD, Chung-Che Chang, MD, PhD, Jennifer L. Herrick, MD, Youli Zu, MD, PhD, Aamir Ehsan, MDAccepted for publication May 21, 2007.From the Department of Pathology, The Methodist Hospital, Houston, Tex (Drs Olsen, Chang, and Zu), the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minn (Dr Herrick), and the Department of Pathology, University of Texas Health Science Center, San Antonio (Dr Ehsan).The authors have no relevant financial interest in the products or companies described in this article.Corresponding author: Youli Zu, MD, PhD, Department of Pathology, The Methodist Hospital, 6565 Fannin St, M227, Houston, TX 77030 (e-mail: yzu@tmhs.org).,;
机译:免疫组织化学在亚型急性淋巴细胞白血病中的诊断效用:2年的经验
机译:下一代测序时代如何对急性髓细胞性白血病和骨髓增生异常综合症进行分子诊断的观点
机译:MicroRNA作为儿童急性淋巴细胞白血病的诊断生物标志物; 系统评论,元分析和建议
机译:一种检测急性淋巴细胞白血病的新方法
机译:诱导高信号作为一种治疗BCR-ABL1阳性急性淋巴细胞白血病(ALL)细胞的治疗方法。
机译:B细胞急性淋巴细胞白血病汽车T细胞治疗后骨髓恶性肿瘤评价的诊断方法
机译:急性髓性白血病的融合基因:是否需要融合RNA测序的急性骨髓白血病诊断?